Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.

0 Comments | M2 Presswire, January, 2008

M2 PRESSWIRE-9 January 2008-BeaconEquityResearch.com: Beacon Equity Research reports on the OTC and OTCBB Trade Leaders: Chemokine Therapeutics Corp. (OTCBB: CHKT), iVoice, Inc. (OTCBB: IVOI), Acro, Inc. (OTCBB: ACRI), Worldwide Manufacturing USA Inc. (OTCBB: WWMU), and CytoGenix, Inc. (OTCBB: CYGX) for January 09, 2008.(C)1994-2008 M2 COMMUNICATIONS LTD

RDATE:09012008

To sign up for our free research reports and newsletters, visit http://beaconequityresearch.com/CHKT

January 08, 2008 - Chemokine Therapeutics Receives Approval From FDA to Commence Phase II Study

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)